当前位置: 首页 >> 检索结果
共有 3922 条符合本次的查询结果, 用时 2.5563685 秒

2021. Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance.

作者: K S Polonsky.;J Sturis.;G I Bell.
来源: N Engl J Med. 1996年334卷12期777-83页

2022. Intracellular pathogenesis of listeriosis.

作者: F S Southwick.;D L Purich.
来源: N Engl J Med. 1996年334卷12期770-6页

2023. Androgens in men--uses and abuses.

作者: C J Bagatell.;W J Bremner.
来源: N Engl J Med. 1996年334卷11期707-14页

2024. Transgenic animals.

作者: A R Shuldiner.
来源: N Engl J Med. 1996年334卷10期653-5页

2025. Surgery for seizures.

作者: J Engel.
来源: N Engl J Med. 1996年334卷10期647-52页

2026. Seminars in medicine of the Beth Israel Hospital, Boston. Adrenergic receptors--evolving concepts and clinical implications.

作者: P A Insel.
来源: N Engl J Med. 1996年334卷9期580-5页

2027. Metformin.

作者: C J Bailey.;R C Turner.
来源: N Engl J Med. 1996年334卷9期574-9页

2028. Acute spinal injury.

作者: B W Chiles.;P R Cooper.
来源: N Engl J Med. 1996年334卷8期514-20页

2029. The management of gout.

作者: B T Emmerson.
来源: N Engl J Med. 1996年334卷7期445-51页
We now have sufficient knowledge to be able to identify the factors contributing to hyperuricemia in most patients with gout. Some of these factors, such as obesity, a high-purine diet, regular alcohol consumption, and diuretic therapy, may be correctable. In patients with persistent hyperuricemia, regular medication should lower the serum urate concentration to an optimal level. The continuing challenge is to educate patients about correctable factors and the importance of regular medication and ensure their compliance so that attacks of gout do not recur.

2030. A medical disaster response to reduce immediate mortality after an earthquake.

作者: C H Schultz.;K L Koenig.;E K Noji.
来源: N Engl J Med. 1996年334卷7期438-44页

2031. Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system.

作者: G M Reaven.;H Lithell.;L Landsberg.
来源: N Engl J Med. 1996年334卷6期374-81页

2032. Antisense-oligonucleotide therapy.

作者: F K Askari.;W M McDonnell.
来源: N Engl J Med. 1996年334卷5期316-8页

2033. Octreotide.

作者: S W Lamberts.;A J van der Lely.;W W de Herder.;L J Hofland.
来源: N Engl J Med. 1996年334卷4期246-54页

2034. Streptococcal infections of skin and soft tissues.

作者: A L Bisno.;D L Stevens.
来源: N Engl J Med. 1996年334卷4期240-5页

2035. Antiepileptic drugs.

作者: M J Brodie.;M A Dichter.
来源: N Engl J Med. 1996年334卷3期168-75页

2036. Obstructive sleep apnea.

作者: P J Strollo.;R M Rogers.
来源: N Engl J Med. 1996年334卷2期99-104页

2037. Cardiac pacing.

作者: F M Kusumoto.;N Goldschlager.
来源: N Engl J Med. 1996年334卷2期89-97页

2038. DNA vaccines.

作者: W M McDonnell.;F K Askari.
来源: N Engl J Med. 1996年334卷1期42-5页

2039. Schizophrenia.

作者: J M Kane.
来源: N Engl J Med. 1996年334卷1期34-41页

2040. Transcription-factor mutations and disease.

作者: D S Latchman.
来源: N Engl J Med. 1996年334卷1期28-33页
共有 3922 条符合本次的查询结果, 用时 2.5563685 秒